Author

Axel Dietschmann

Friedrich-Alexander-Universität Erlangen-NürnbergORCID 0000-0002-0598-9714Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Immunology· 1 Microbiology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Organism:mouse· 2 Assay:bulk RNA-seq· 1 Research Focus:cell type annotation· 1 Approach:deep learning· 1 Approach:experimental assay· 1 Research Focus:gene regulatory network inference· 1 Research Focus:host-pathogen & immune response· 1 Organism:human· 1

Frequent Co-Authors

Anahita Sedighi· 1 shared Bart EvertsiD· 1 shared Bernhard HubeiD· 1 shared Birgit NiederreiteriD· 1 shared Chiara BrachelenteiD· 1 shared Christoph BeckeriD· 1 shared David VoehringeriD· 1 shared Dennis Marinus de GraafiD· 1 shared

Activity by Year

2025-2026 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 21 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Anahita Sedighi

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

MicrobiologybioRxivPreprintJan 22, 2026

Local albumin excess exacerbates Candida albicans-induced inflammasome activation underlying the immunopathology of vulvovaginal candidiasis.

Sophie Austermeier, Axel Dietschmann, Gianluca Vascelli…·Mark S. Gresnigt

This study shows that local albumin excess in the vagina exacerbates Candida albicans-induced inflammasome activation, contributing to hyperinflammation in vulvovaginal candidiasis.

DOI 10.64898/2026.01.22.700771

humanmouse

𝕏 PostBluesky

ImmunologybioRxivPreprintNov 3, 2025

IRF4 is a master regulator of multinucleated giant cell formation

Melanie Hofmann, Gerwin Heller, Markus Kieler…·Gernot Schabbauer

This study identifies IRF4 as a master regulator of multinucleated giant cell formation through integrated single-cell and bulk RNA sequencing, CRISPR/Cas9 editing, and in vivo fate mapping.

1 citation

mousescRNA-seq

𝕏 PostBluesky